Targeting myeloma cell growth factors in multiple myeloma

被引：0
作者：
Klein, B.
Hose, D.
Moreaux, J.
De Vos, J.
Jourdan, M.
Sprinsky, A. C.
Jourdan, E.
Reme, T.
Mahtouk, K.
Goldschmidt, H.
Rossi, J. F.
机构：
[1] CHU Montpellier, Hop St Eloi, Inst Rech Biotherapies, Montpellier, France
[2] INSERM, U847, Montpellier, France
[3] Univ Montpellier 1, UFR Med, Montpellier, France
[4] Univ Klinikum Heidelberg, INF410, Med Klin & Poliklin 5, Heidelberg, Germany
[5] CHU Montpellier, Serv Hematol & Oncol, Montpellier, France
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 44
页数：2
相关论文
共 11 条
  • [1] Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays
    De Vos, J
    Thykjær, T
    Tarte, K
    Ensslen, M
    Raynaud, P
    Requirand, G
    Pellet, F
    Pantesco, V
    Rème, T
    Jourdan, M
    Rossi, JF
    Orntoft, T
    Klein, B
    [J]. ONCOGENE, 2002, 21 (44) : 6848 - 6857
  • [2] Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway
    Ferlin, M
    Noraz, N
    Hertogh, C
    Brochier, J
    Taylor, N
    Klein, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) : 626 - 634
  • [3] Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors
    Gu, ZJ
    De Vos, J
    Rebouissou, C
    Jourdan, M
    Zhang, XG
    Rossi, JF
    Wijdenes, J
    Klein, B
    [J]. LEUKEMIA, 2000, 14 (01) : 188 - 197
  • [4] Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
    Mahtouk, K.
    Cremer, F. W.
    Reme, T.
    Jourdan, M.
    Baudard, M.
    Moreaux, J.
    Requirand, G.
    Fiol, G.
    De Vos, J.
    Moos, M.
    Quittet, P.
    Goldschmidt, H.
    Rossi, J-F
    Hose, D.
    Klein, B.
    [J]. ONCOGENE, 2006, 25 (54) : 7180 - 7191
  • [5] Expression of EGF-family receptors and amphiregulin in multiple myeloma.: Amphiregulin is a growth factor for myeloma cells
    Mahtouk, K
    Hose, D
    Rème, T
    De Vos, J
    Jourdan, M
    Moreaux, J
    Fiol, G
    Raab, M
    Jourdan, E
    Grau, V
    Moos, M
    Goldschmidt, H
    Baudard, M
    Rossi, JF
    Cremer, FW
    Klein, B
    [J]. ONCOGENE, 2005, 24 (21) : 3512 - 3524
  • [6] An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis
    Mahtouk, K
    Jourdan, M
    De Vos, J
    Hertogh, C
    Fiol, G
    Jourdan, E
    Rossi, JF
    Klein, B
    [J]. BLOOD, 2004, 103 (05) : 1829 - 1837
  • [7] Mahtouk K, 2007, BLOOD
  • [8] The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
    Moreaux, J
    Cremer, FW
    Reme, T
    Raab, M
    Mahtouk, K
    Kaukel, P
    Pantesco, V
    De Vos, J
    Jourdan, E
    Jauch, A
    Legouffe, E
    Moos, M
    Fiol, G
    Goldschmidt, H
    Rossi, JF
    Hose, D
    Klein, B
    [J]. BLOOD, 2005, 106 (03) : 1021 - 1030
  • [9] BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
    Moreaux, J
    Legouffe, E
    Jourdan, E
    Quittet, P
    Rème, T
    Lugagne, C
    Moine, P
    Rossi, JF
    Klein, B
    Tarte, K
    [J]. BLOOD, 2004, 103 (08) : 3148 - 3157
  • [10] ZHANG XG, 1992, CANCER, V69, P1373, DOI 10.1002/1097-0142(19920315)69:6<1373::AID-CNCR2820690612>3.0.CO
12